CD23/FcεRII: Molecular multi-tasking

Clinical and Experimental Immunology

Volumn 162, Issue 1, 2010, Pages 12-23

  Acharya, M ^a   Borland, G ^a   Edkins, A L ^a   MacLellan, L M ^a   Matheson, J ^c   Ozanne, B W ^b   Cushley, W ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c NONE

Author keywords

CD23; cytokines; IgE; immunoregulation; integrins

Indexed keywords

CD23 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN E; INTEGRIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; BONE MARROW CELL; CELL SURFACE; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; INFLAMMATION; MOLECULAR BIOLOGY; NEOPLASM; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IGE;

EID: 77956529454     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04210.x     Document Type: Review

References (127)

1. Ludin C, Hofstetter H, Sarfati M et al. Cloning and expression of the cDNA coding for a human lymphocyte IgE receptor. EMBO J 1987 6 : 109 114.
2. Suter U, Bastos R, Hofstetter H. Molecular structure of the gene and the 5′-flanking region of the human lymphocyte immunoglobulin E receptor. Nucleic Acids Res 1987 15 : 7295 7308.
3. Conrad DH, Ford JW, Sturgill JL, Gibb DR. CD23: an overlooked regulator of allergic disease. Curr Allergy Asthma Rep 2007 7 : 331 337.
4. Bonnefoy JY, Lecoanet-Henchoz S, Gauchat JF et al. Structure and functions of CD23. Int Rev Immunol 1997 16 : 113 128.
5. Gould HJ, Sutton BJ, Beavil AJ et al. The biology of IGE and the basis of allergic disease. Annu Rev Immunol 2003 21 : 579 628.
6. Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol 2008 8 : 205 217.
7. Sarfati M, Fournier S, Wu CY, Delespesse G. Expression, regulation and function of human Fc epsilon RII (CD23) antigen. Immunol Res 1992 11 : 260 272.
8. Armitage RJ, Goff LK, Beverley PC. Expression and functional role of CD23 on T cells. Eur J Immunol 1989 19 : 31 5.
9. Yamaoka KA, Arock M, Issaly F, Dugas N, Le Goff L, Kolb JP. Granulocyte macrophage colony stimulating factor induces Fc epsilon RII/CD23 expression on normal human polymorphonuclear neutrophils. Int Immunol 1996 8 : 479 490.
10. Kikutani H, Yokota A, Uchibayashi N et al. Structure and function of Fc epsilon receptor II (Fc epsilon RII/CD23): a point of contact between the effector phase of allergy and B cell differentiation. Ciba Found Symp 1989 147 : 23 31 discussion 31 5.
11. Capron M, Truong MJ, Aldebert D et al. Eosinophil IgE receptor and CD23. Immunol Res 1992 11 : 252 259.
12. Vercelli D, Jabara HH, Lee BW, Woodland N, Geha RS, Leung DY. Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes. J Exp Med 1988 167 : 1406 1416.
13. Rieber EP, Rank G, Kohler I, Krauss S. Membrane expression of Fc epsilon RII/CD23 and release of soluble CD23 by follicular dendritic cells. Adv Exp Med Biol 1993 329 : 393 398.
14. Yu LC, Montagnac G, Yang PC, Conrad DH, Benmerah A, Perdue MH. Intestinal epithelial CD23 mediates enhanced antigen transport in allergy: evidence for novel splice forms. Am J Physiol Gastrointest Liver Physiol 2003 285 : G223 34.
15. Fourcade C, Arock M, Ktorza S et al. Expression of CD23 by human bone marrow stromal cells. Eur Cytokine Netw 1992 3 : 539 543.
16. Wendel-Hansen V, Riviere M, Uno M et al. The gene encoding CD23 leukocyte antigen (FCE2) is located on human chromosome 19. Somat Cell Mol Genet 1990 16 : 283 286.
17. Soilleux EJ, Barten R, Trowsdale J. DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol 2000 165 : 2937 2942.
18. Conrad DH, Kozak CA, Vernachio J, Squire CM, Rao M, Eicher EM. Chromosomal location and isoform analysis of mouse Fc epsilon RII/CD23. Mol Immunol 1993 30 : 27 33.
19. Zhang M, Murphy RF, Agrawal DK. Decoding IgE Fc receptors. Immunol Res 2007 37 : 1 16.
20. Kilmon MA, Shelburne AE, Chan-Li Y, Holmes KL, Conrad DH. CD23 trimers are preassociated on the cell surface even in the absence of its ligand, IgE. J Immunol 2004 172 : 1065 1073.
21. Bournazos S, Woof JM, Hart SP, Dransfield I. Functional and clinical consequences of Fc receptor polymorphic and copy number variants. Clin Exp Immunol 2009 157 : 244 254.
22. Holowka D, Sil D, Torigoe C, Baird B. Insights into immunoglobulin E receptor signaling from structurally defined ligands. Immunol Rev 2007 217 : 269 279.
23. Rivera J, Fierro NA, Olivera A, Suzuki R. New insights on mast cell activation via the high affinity receptor for IgE. Adv Immunol 2008 98 : 85 120.
24. Weskamp G, Ford JW, Sturgill J et al. ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat Immunol 2006 7 : 1293 1298.
25. Lemieux GA, Blumenkron F, Yeung N et al. The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J Biol Chem 2007 282 : 14836 14844.
26. Gibb DR, El Shikh M, Kang DJ et al. ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo. J Exp Med 2010 207 : 623 635.
27. Schulz O, Laing P, Sewell HF, Shakib F. Der p I, a major allergen of the house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23). Eur J Immunol 1995 25 : 3191 3194.
28. Schulz O, Sutton BJ, Beavil RL et al. Cleavage of the low-affinity receptor for human IgE (CD23) by a mite cysteine protease: nature of the cleaved fragment in relation to the structure and function of CD23. Eur J Immunol 1997 27 : 584 588.
29. McCloskey N, Hunt J, Beavil RL et al. Soluble CD23 monomers inhibit and oligomers stimulate IGE synthesis in human B cells. J Biol Chem 2007 282 : 24083 24091.
30. Cairns JA, Gordon J. Intact, 45-kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts. Eur J Immunol 1990 20 : 539 543.
31. Gordon J, Flores-Romo L, Cairns JA et al. CD23: a multi-functional receptor/lymphokine? Immunol Today 1989 10 : 153 157.
32. Gordon J, Rowe M, Walker L, Guy G. Ligation of the CD23,p45 (BLAST-2,EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes. Eur J Immunol 1986 16 : 1075 1080.
33. Liu YJ, Cairns JA, Holder MJ et al. Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 1991 21 : 1107 1114.
34. White LJ, Ozanne BW, Graber P, Aubry JP, Bonnefoy JY, Cushley W. Inhibition of apoptosis in a human pre-B-cell line by CD23 is mediated via a novel receptor. Blood 1997 90 : 234 243.
35. Mossalayi MD, Arock M, Bertho JM et al. Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23. Blood 1990 75 : 1924 1927.
36. Mossalayi MD, Lecron JC, Dalloul AH et al. Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation. J Exp Med 1990 171 : 959 964.
37. Bertho JM, Fourcade C, Dalloul AH, Debre P, Mossalayi MD. Synergistic effect of interleukin 1 and soluble CD23 on the growth of human CD4+ bone marrow-derived T cells. Eur J Immunol 1991 21 : 1073 1076.
38. Hermann P, Armant M, Brown E et al. The vitronectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23. J Cell Biol 1999 144 : 767 775.
39. Aubry JP, Pochon S, Graber P, Jansen KU, Bonnefoy JY. CD21 is a ligand for CD23 and regulates IgE production. Nature 1992 358 : 505 507.
40. Aubry JP, Pochon S, Gauchat JF et al. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J Immunol 1994 152 : 5806 5813.
41. Fremeaux-Bacchi V, Fischer E, Lecoanet-Henchoz S, Mani JC, Bonnefoy JY, Kazatchkine MD. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells. Int Immunol 1998 10 : 1459 1466.
42. Bjorck P, Elenstrom-Magnusson C, Rosen A, Severinson E, Paulie S. CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes. Eur J Immunol 1993 23 : 1771 1775.
43. Davey EJ, Bartlett WC, Kikutani H et al. Homotypic aggregation of murine B lymphocytes is independent of CD23. Eur J Immunol 1995 25 : 1224 1229.
44. Hibbert RG, Teriete P, Grundy GJ et al. The structure of human CD23 and its interactions with IgE and CD21. J Exp Med 2005 202 : 751 760.
45. Kijimoto-Ochiai S, Noguchi A. Two peptides from CD23, including the inverse RGD sequence and its related peptide, interact with the MHC class II molecule. Biochem Biophys Res Commun 2000 267 : 686 691.
46. Flores-Romo L, Johnson GD, Ghaderi AA, Stanworth DR, Veronesi A, Gordon J. Functional implication for the topographical relationship between MHC class II and the low-affinity IgE receptor: occupancy of CD23 prevents B lymphocytes from stimulating allogeneic mixed lymphocyte responses. Eur J Immunol 1990 20 : 2465 2469.
47. Lecoanet-Henchoz S, Gauchat JF, Aubry JP et al. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 1995 3 : 119 125.
48. Lecoanet-Henchoz S, Plater-Zyberk C, Graber P et al. Mouse CD23 regulates monocyte activation through an interaction with the adhesion molecule CD11b/CD18. Eur J Immunol 1997 27 : 2290 2294.
49. Rezzonico R, Chicheportiche R, Imbert V, Dayer JM. Engagement of CD11b and CD11c beta2 integrin by antibodies or soluble CD23 induces IL-1β production on primary human monocytes through mitogen-activated protein kinase-dependent pathways. Blood 2000 95 : 3868 3877.
50. Rezzonico R, Imbert V, Chicheportiche R, Dayer JM. Ligation of CD11b and CD11c β integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta production in primary human monocytes through a pathway dependent on nuclear factor-kappaB. Blood 2001 97 : 2932 2940.
51. Borland G, Edkins AL, Acharya M et al. αvβ5 integrin sustains growth of human pre-B cells through an RGD-independent interaction with a basic domain of the CD23 protein. J Biol Chem 2007 282 : 27315 27326.
52. Acharya M, Edkins AL, Ozanne BW, Cushley W. SDF-1 and PDGF enhance αvβ5-mediated ERK activation and adhesion-independent growth of human pre-B cell lines. Leukemia 2009 23 : 1807 1817.
53. Wurzburg BA, Tarchevskaya SS, Jardetzky TS. Structural changes in the lectin domain of CD23, the low-affinity IgE receptor, upon calcium binding. Structure 2006 14 : 1049 1058.
54. Mossalayi MD, Arock M, Delespesse G et al. Cytokine effects of CD23 are mediated by an epitope distinct from the IgE binding site. EMBO J 1992 11 : 4323 4328.
55. Yokota A, Kikutani H, Tanaka T et al. Two species of human Fc ε receptor II (Fc ε RII/CD23): tissue-specific and IL-4-specific regulation of gene expression. Cell 1988 55 : 611 618.
56. Wang F, Kikutani H, Tsang SF, Kishimoto T, Kieff E. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J Virol 1991 65 : 4101 4106.
57. Defrance T, Aubry JP, Rousset F et al. Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes. J Exp Med 1987 165 : 1459 1467.
58. Gordon J, Katira A, Strain AJ, Gillis S. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overriden on engaging CD40. Eur J Immunol 1991 21 : 1917 1922.
59. Ewart MA, Ozanne BW, Cushley W. The CD23a and CD23b proximal promoters display different sensitivities to exogenous stimuli in B lymphocytes. Genes Immun 2002 3 : 158 164.
60. Kolb JP, Renard D, Dugas B et al. Monoclonal anti-CD23 antibodies induce a rise in [Ca2+]i and polyphosphoinositide hydrolysis in human activated B cells. Involvement of a Gp protein. J Immunol 1990 145 : 429 437.
61. Kolb JP, Abadie A, Paul-Eugene N et al. Ligation of CD23 triggers cyclic AMP generation in human B lymphocytes. J Immunol 1993 150 : 4798 4809.
62. Kolb JP, Paul-Eugene Dugas N, Yamaoka K, Mossalayi MD, Dugas B. Role of CD23 in NO production by human monocytic cells. Res Immunol 1995 146 : 684 689.
63. Sugie K, Kawakami T, Maeda Y, Kawabe T, Uchida A, Yodoi J. Fyn tyrosine kinase associated with Fc epsilon RII/CD23: possible multiple roles in lymphocyte activation. Proc Natl Acad Sci USA 1991 88 : 9132 9135.
64. Yokota A, Yukawa K, Yamamoto A et al. Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains. Proc Natl Acad Sci USA 1992 89 : 5030 5034.
65. Karagiannis SN, Warrack JK, Jennings KH et al. Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells. Immunology 2001 103 : 319 331.
66. Yu P, Kosco-Vilbois M, Richards M, Kohler G, Lamers MC. Negative feedback regulation of IgE synthesis by murine CD23. Nature 1994 369 : 753 756.
67. Ford JW, Sturgill JL, Conrad DH. 129/SvJ mice have mutated CD23 and hyper IgE. Cell Immunol 2009 254 : 124 134.
68. Lewis G, Rapsomaniki E, Bouriez T et al. Hyper IgE in New Zealand black mice due to a dominant-negative CD23 mutation. Immunogenetics 2004 56 : 564 571.
69. Payet M, Conrad DH. IgE regulation in CD23 knockout and transgenic mice. Allergy 1999 54 : 1125 1129.
70. Payet ME, Woodward EC, Conrad DH. Humoral response suppression observed with CD23 transgenics. J Immunol 1999 163 : 217 223.
71. Carlsson F, Hjelm F, Conrad DH, Heyman B. IgE enhances specific antibody and T-cell responses in mice overexpressing CD23. Scand J Immunol 2007 66 : 261 270.
72. Getahun A, Hjelm F, Heyman B. IgE enhances antibody and T cell responses in vivo via CD23+ B cells. J Immunol 2005 175 : 1473 1482.
73. Westman S, Gustavsson S, Heyman B. Early expansion of secondary B cells after primary immunization with antigen complexed with IgE. Scand J Immunol 1997 46 : 10 5.
74. Gustavsson S, Hjulstrom S, Liu T, Heyman B. CD23/IgE-mediated regulation of the specific antibody response in vivo. J Immunol 1994 152 : 4793 4800.
75. Fujiwara H, Kikutani H, Suematsu S et al. The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc Natl Acad Sci USA 1994 91 : 6835 6839.
76. Gustavsson S, Wernersson S, Heyman B. Restoration of the antibody response to IgE/antigen complexes in CD23-deficient mice by CD23+ spleen or bone marrow cells. J Immunol 2000 164 : 3990 3995.
77. Hjelm F, Karlsson MC, Heyman B. A novel B cell-mediated transport of IgE-immune complexes to the follicle of the spleen. J Immunol 2008 180 : 6604 6610.
78. Bevilacqua C, Montagnac G, Benmerah A et al. Food allergens are protected from degradation during CD23-mediated transepithelial transport. Int Arch Allergy Immunol 2004 135 : 108 116.
79. Montagnac G, Yu LC, Bevilacqua C et al. Differential role for CD23 splice forms in apical to basolateral transcytosis of IgE/allergen complexes. Traffic 2005 6 : 230 242.
80. Montagnac G, Molla-Herman A, Bouchet J et al. Intracellular trafficking of CD23: differential regulation in humans and mice by both extracellular and intracellular exons. J Immunol 2005 174 : 5562 5572.
81. Kaiserlian D, Lachaux A, Grosjean I, Graber P, Bonnefoy JY. CD23/FC epsilon RII is constitutively expressed on human intestinal epithelium, and upregulated in cow's milk protein intolerance. Adv Exp Med Biol 1995 371B : 871 874.
82. Laitinen T, Ollikainen V, Lazaro C et al. Association study of the chromosomal region containing the FCER2 gene suggests it has a regulatory role in atopic disorders. Am J Respir Crit Care Med 2000 161 : 700 706.
83. Tello-Ruiz MK, Curley C, DelMonte T et al. Haplotype-based association analysis of 56 functional candidate genes in the IBD6 locus on chromosome 19. Eur J Hum Genet 2006 14 : 780 790.
84. Tantisira KG, Silverman ES, Mariani TJ et al. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol 2007 120 : 1285 1291.
85. Rogers AJ, Tantisira KG, Fuhlbrigge AL et al. Predictors of poor response during asthma therapy differ with definition of outcome. Pharmacogenomics 2009 10 : 1231 1242.
86. Chan KY, Ching JC, Xu MS et al. Association of ICAM3 genetic variant with severe acute respiratory syndrome. J Infect Dis 2007 196 : 271 280.
87. Li H, Tang NL, Chan PK et al. Polymorphisms in the C-type lectin genes cluster in chromosome 19 and predisposition to severe acute respiratory syndrome coronavirus (SARS-CoV) infection. J Med Genet 2008 45 : 752 758.
88. Shen M, Vermeulen R, Rajaraman P et al. Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. Environ Mol Mutagen 2009 50 : 285 290.
89. Potaczek DP, Wang QH, Sanak M et al. Interaction of functional FCER2 promoter polymorphism and phenotype-associated haplotypes. Tissue Antigens 2009 74 : 534 538.
90. Meng JF, McFall C, Rosenwasser LJ. Polymorphism R62W results in resistance of CD23 to enzymatic cleavage in cultured cells. Genes Immun 2007 8 : 215 223.
91. Barna G, Reiniger L, Tatrai P, Kopper L, Matolcsy A. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL. Hematol Oncol 2008 26 : 167 170.
92. Schlette E, Fu K, Medeiros LJ. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. Am J Clin Pathol 2003 120 : 760 766.
93. Walters M, Olteanu H, Van Tuinen P, Kroft SH. CD23 expression in plasma cell myeloma is specific for abnormalities of chromosome 11, and is associated with primary plasma cell leukaemia in this cytogenetic sub-group. Br J Haematol 2010 149 : 292 293.
94. Soriano AO, Thompson MA, Admirand JH et al. Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature. Am J Hematol 2007 82 : 725 728.
95. Vitolo U, Ferreri AJ, Montoto S. Follicular lymphomas. Crit Rev Oncol Hematol 2008 66 : 248 261.
96. Thorley-Lawson DA, Nadler LM, Bhan AK, Schooley RT. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. J Immunol 1985 134 : 3007 3012.
97. Salama ME, Mariappan MR, Inamdar K, Tripp SR, Perkins SL. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma. Int J Surg Pathol 2010 18 : 121 128.
98. Caligaris-Cappio F, Ghia P. The normal counterpart to the chronic lymphocytic leukemia B cell. Best Pract Res Clin Haematol 2007 20 : 385 397.
99. Ghia P, Ferreri AM, Caligaris-Cappio F. Chronic lymphocytic leukemia. Crit Rev Oncol Hematol 2007 64 : 234 246.
100. Goller ME, Kneitz C, Mehringer C et al. Regulation of CD23 isoforms on B-chronic lymphocytic leukemia. Leuk Res 2002 26 : 795 802.
101. Fournier S, Rubio M, Delespesse G, Sarfati M. Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. Blood 1994 84 : 1881 1886.
102. Fournier S, Yang LP, Delespesse G, Rubio M, Biron G, Sarfati M. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia. Br J Haematol 1995 89 : 373 379.
103. Sarfati M, Bron D, Lagneaux L, Fonteyn C, Frost H, Delespesse G. Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia. Blood 1988 71 : 94 8.
104. Sarfati M, Chevret S, Chastang C et al. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood 1996 88 : 4259 4264.
105. Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F, Packham G. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood 2003 101 : 1087 1093.
106. Rassenti LZ, Huynh L, Toy TL et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004 351 : 893 901.
107. Meuleman N, Stamatopoulos B, Dejeneffe M, El Housni H, Lagneaux L, Bron D. Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients. Leukemia 2008 22 : 1882 1890.
108. Bansal A, Roberts T, Hay EM, Kay R, Pumphrey RS, Wilson PB. Soluble CD23 levels are elevated in the serum of patients with primary Sjogren's syndrome and systemic lupus erythematosus. Clin Exp Immunol 1992 89 : 452 455.
109. Takei M, Azuhata T, Yoshimatu T et al. Increased soluble CD23 molecules in serum/saliva and correlation with the stage of sialoectasis in patients with primary Sjogren's syndrome. Clin Exp Rheumatol 1995 13 : 711 715.
110. Bansal AS, MacGregor AJ, Pumphrey RS, Silman AJ, Ollier WE, Wilson PB. Increased levels of sCD23 in rheumatoid arthritis are related to disease status. Clin Exp Rheumatol 1994 12 : 281 285.
111. Massa M, Pignatti P, Oliveri M, De Amici M, De Benedetti F, Martini A. Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis. Clin Exp Rheumatol 1998 16 : 611 616.
112. Huissoon AP, Emery P, Bacon PA, Gordon J, Salmon M. Increased expression of CD23 in rheumatoid synovitis. Scand J Rheumatol 2000 29 : 154 159.
113. Ribbens C, Bonnet V, Kaiser MJ et al. Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA). Clin Exp Immunol 2000 120 : 194 199.
114. Taylor PC, Feldmann M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol 2009 5 : 578 582.
115. Flores-Romo L, Shields J, Humbert Y et al. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science 1993 261 : 1038 1041.
116. Plater-Zyberk C, Bonnefoy JY. Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo. Nat Med 1995 1 : 781 785.
117. Byrd JC, Kipps TJ, Flinn IW et al. Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia. Blood 2010 115 : 489 495.
118. Pathan NI, Chu P, Hariharan K, Cheney C, Molina A, Byrd J. Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines. Blood 2008 111 : 1594 1602.
119. Poole JA, Meng J, Reff M, Spellman MC, Rosenwasser LJ. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol 2005 116 : 780 788.
120. Karagiannis SN, Bracher MG, Beavil RL et al. Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells. Cancer Immunol Immunother 2008 57 : 247 263.
121. Karagiannis SN, Bracher MG, Hunt J et al. IgE-antibody-dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cells. J Immunol 2007 179 : 2832 2843.
122. Karagiannis P, Singer J, Hunt J et al. Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells. Cancer Immunol Immunother 2009 58 : 915 930.
123. Mossalayi MD, Vouldoukis I, Mamani-Matsuda M et al. CD23 mediates antimycobacterial activity of human macrophages. Infect Immun 2009 77 : 5537 5542.
124. Wilder RL. Integrin αvβ3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis 2002 61 (Suppl. 2 ii96 9.
125. Cai W, Chen X. Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism. Anticancer Agents Med Chem 2006 6 : 407 428.
126. Rambert J, Mamani-Matsuda M, Moynet D et al. Molecular blocking of CD23 supports its role in the pathogenesis of arthritis. PLoS One 2009 4 : e4834.
127. Wan T, Beavil RL, Fabiane SM et al. The crystal structure of IgE Fc reveals an asymmetrically bent conformation. Nat Immunol 2002 3 : 681 686.